共 50 条
- [32] Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis FRONTIERS IN ONCOLOGY, 2021, 11
- [34] Efficacy and Safety of PD-1/PD-L1 Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis Advances in Therapy, 2023, 40 : 521 - 549
- [38] A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer ONCOTARGETS AND THERAPY, 2019, 12 : 1791 - 1801
- [40] Cardiovascular adverse events and immune-related adverse events associated with PD-1/PD-L1 inhibitors for head and neck squamous cell carcinoma (HNSCC) SCIENTIFIC REPORTS, 2024, 14 (01):